United States · 
Who invested in Avammune Therapeutics?
Avammune Therapeutics's investors include Y Combinator.
United States · Series A startup
Who invested in Avammune Therapeutics
Funding summaryUpdated 26 Oct 2026
$12Mraised across 1 round since 2025, from 1 source
- Latest round
- Series A, $12MMay 2025
- Investors
- 1
The rounds
- May 2025
Founders and team
From Avammune Therapeutics's own website: 3 founders, 3 on the team.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Avammune Therapeutics
How much has Avammune Therapeutics raised?
Avammune Therapeutics has raised $12M across 1 round since 2025.
When did Avammune Therapeutics last raise?
Avammune Therapeutics's most recent round was a Series A of $12M in May 2025.
What was Avammune Therapeutics's biggest round?
Its most recent round, $12M in May 2025, is also its largest on record.
Who backed Avammune Therapeutics first?
Avammune Therapeutics's first round on record, in May 2025, was backed by Y Combinator.
What stage is Avammune Therapeutics at?
Avammune Therapeutics's latest named round is a Series A, in May 2025.
Where is Avammune Therapeutics based?
Avammune Therapeutics is based in the United States.
Companies like Avammune Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.